BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33428786)

  • 1. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
    Koemans WJ; van der Kaaij RT; Wassenaar ECE; Boerma D; Boot H; Sikorska K; Los M; Grootscholten C; Hartemink KJ; Veenhof AAFA; Kodach L; Snaebjornsson P; van Sandick JW
    J Surg Oncol; 2021 Mar; 123(4):904-910. PubMed ID: 33428786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
    Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
    Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.
    Yan G; Zhang K; Yan L; Zhang Y
    World J Surg Oncol; 2024 May; 22(1):144. PubMed ID: 38822337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.
    Seshadri RA; Glehen O
    World J Gastroenterol; 2016 Jan; 22(3):1114-30. PubMed ID: 26811651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer with Peritoneal Dissemination (PERISCOPE II).
    Sarvestani AL; Gregory SN; Akmal SR; Hernandez JM; van der Sluis K; van Sandick JW
    Ann Surg Oncol; 2024 Jan; 31(1):28-30. PubMed ID: 37947975
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
    Götze TO; Piso P; Lorenzen S; Bankstahl US; Pauligk C; Elshafei M; Amato G; Reim D; Bechstein WO; Königsrainer A; Mönig SP; Rau B; Schwarzbach M; Al-Batran SE
    BMC Cancer; 2021 Oct; 21(1):1158. PubMed ID: 34715810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
    Guo J; Deng Z; Jin L; Yin S; Xiong Z; Wang C; Chen H; Luo D; Huang D; Peng J; Chen S; Lian L
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17881-17896. PubMed ID: 37947869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Buckarma E; Thiels CA; Jin Z; Grotz TE
    Ann Surg Oncol; 2024 Jan; 31(1):622-629. PubMed ID: 37880514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
    Fisher OM; Brown C; Esquivel J; Larsen SG; Liauw W; Alzahrani NA; Morris DL; Kepenekian V; Sourrouille I; Dumont F; Tuech JJ; Ceribelli C; Doussot B; Sgarbura O; Alhosni M; Quenet F; Glehen O; Cashin PH;
    BJS Open; 2024 May; 8(3):. PubMed ID: 38722737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat cytoreduction with Hyperthermic Intraperitoneal chemotherapy in patients with peritoneal disease: A 5-year retrospective analysis.
    Mendes J; Marques S; Peyroteo M; Lobo M; Sousa F; Fernandes M; Videira JF; de Sousa A
    Surg Oncol; 2024 Jun; 54():102078. PubMed ID: 38640857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Japanese practice of comprehensive treatment for peritoneal metastasis of gastric cancer].
    Liu Y; Yutaka CL; Toshiyuki LX; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):992-996. PubMed ID: 37849272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis.
    Liu L; Zheng L; Liu S; Zhang M; Zhang S; Jiang Z; Qin C; Wang D
    J Gastrointest Surg; 2023 Nov; 27(11):2297-2307. PubMed ID: 37715013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.
    Tonello M; Sommariva A
    Ann Surg Oncol; 2024 Mar; 31(3):2008-2009. PubMed ID: 37851201
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.
    Hall JJ; Loggie BW; Shen P; Beamer S; Douglas Case L; McQuellon R; Geisinger KR; Levine EA
    J Gastrointest Surg; 2004; 8(4):454-63. PubMed ID: 15120371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma.
    Liu H; Yuan C; Huang Y; Xu N
    Asian J Surg; 2023 Dec; 46(12):5747-5748. PubMed ID: 37652775
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
    Zwanenburg ES; El Klaver C; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt-Kerkhof ARM; Bremers AJA; Burger PJWA; Fabry HFJ; Ferenschild FTJ; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Kusters M; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden A; Dijkgraaf MGW; Tanis PJ; ;
    J Clin Oncol; 2024 Jan; 42(2):140-145. PubMed ID: 37922442
    [No Abstract]   [Full Text] [Related]  

  • 17. Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer.
    Badgwell B; Estrella J; Roy-Chowdhuri S; Ikoma N; Blum Murphy M; Ajani J; Mansfield P
    Ann Surg Oncol; 2024 May; 31(5):2824-2825. PubMed ID: 38286882
    [No Abstract]   [Full Text] [Related]  

  • 18. A narrative review of what can HIPEC do.
    Sugarbaker PH
    Eur J Surg Oncol; 2023 Sep; 49(9):106976. PubMed ID: 37453879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma-A pilot study in a tertiary Asian centre.
    Seo CJ; Tan JW; Farid M; Wong JSM; Soo KC; Chia CS; Ong CJ
    PLoS One; 2024; 19(4):e0300594. PubMed ID: 38574044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Carcinomatosis: The Need for Clear Answers Through Proper Questions.
    Salani F; Vivaldi C; Rreka E; Genovesi V; Masi G; Lippolis PV; Fornaro L
    J Clin Oncol; 2024 May; 42(15):1861-1862. PubMed ID: 38484188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.